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Abstract
Background: Eps15 homology (EH) domains are protein interaction modules binding to peptides
containing Asn-Pro-Phe (NPF) motifs and mediating critical events during endocytosis and signal
transduction. The EH domain of POB1 associates with Eps15, a protein characterized by a striking
string of DPF triplets, 15 in human and 13 in mouse Eps15, at the C-terminus and lacking the typical
EH-binding NPF motif.
Results: By screening a multivalent nonapeptide phage display library we have demonstrated that
the EH domain of POB1 has a different recognition specificity since it binds to both NPF and DPF
motifs. The region of mouse Eps15 responsible for the interaction with the EH domain of POB1
maps within a 18 amino acid peptide (residues 623–640) that includes three DPF repeats. Finally,
mutational analysis in the EH domain of POB1, revealed that several solvent exposed residues,
while distal to the binding pocket, mediate specific recognition of binding partners through both
hydrophobic and electrostatic contacts.
Conclusion: In the present study we have analysed the binding specificity of the POB1 EH domain.
We show that it differs from other EH domains since it interacts with both NPF- and DPF-
containing sequences. These unusual binding properties could be attributed to a different
conformation of the binding pocket that allows to accommodate negative charges; moreover, we
identified a cluster of solvent exposed Lys residues, which are only found in the EH domain of
POB1, and influence binding to both NPF and DPF motifs. The characterization of structures of the
DPF ligands described in this study and the POB1 EH domain will clearly determine the involvement
of the positive patch and the rationalization of our findings.
Background
The Eps homology (EH) domain is an evolutionary con-
served protein interaction module originally identified as
a tandem repeat of approximately 100 amino acids at the
N-terminus of the proteins Eps15 and Eps15R [1]. When
functional information is available, EH-containing pro-
teins are often implicated in regulation of protein trans-
port and membrane traffic [1,2], in actin cytoskeleton
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organization [2] and in tyrosine kinase signaling path-
ways [3-6].
Screening with a multivalent nonapeptide phage display
library has identified peptides containing an NPF (Asn-
Pro-Phe) motif as the preferred ligands of EH domains
[3]. While the tripeptide motif is essential for binding,
flanking amino acids contribute to modulate binding
affinity [7]. A more detailed characterization of several EH
domains, by phage display, has revealed that some EH
domains may also bind to peptides characterized by dif-
ferent motifs [7]. The NPF-containing peptides are desig-
nated class I peptides; class II peptides are characterized by
Trp-Trp (WW), Phe-Trp (FW), or Ser-Gly-Trp (SGW) con-
sensus sequences while the EH domain of the yeast pro-
tein End3p binds class III peptides containing the His-Ser/
Thr-Phe motif [7]. However, till now, no class II or class
III motifs have been found to be involved in EH domain
recognition in physiological processes.
The structures of five different EH domains have been
determined [8-12] and the molecular and structural bases
of their binding to class I peptides have been elucidated.
The EH domains are formed by two closely associated
helix-loop-helix motifs connected by a short antiparallel
β-sheet. Comparison of the amino acid sequences of dif-
ferent EH domains indicates that the structurally critical
residues involved in the packing of the hydrophobic core
are highly conserved throughout the family [11]. Binding
to the NPF motif is mediated by a conserved hydrophobic
pocket formed by Leu155, Leu165 and Trp169 in the second
EH domain of Eps15. Mutations in Leu165 and Trp169 were
shown to abolish the binding to NPF-containing peptides
[7,11].
POB1 (Partner of RalBP1) was isolated by yeast two-
hybrid screening as a novel interactor of RalBP1 (Ral-
binding protein 1), a putative effector protein of Ral [6].
The single EH domain (Fig. 1) is located at the N-terminus
of POB1 (residues 282–373 in human POB1) and it is
responsible for the interaction with Epsin and Eps15
[13,14], while the C-terminal region has two prolin-rich
motifs (residues 477–484 and residues 513–524), which
associate with the SH3 domain of Grb2 and with PAG2
[14,15] and a coiled-coil structure that maps inside the
region involved in the interaction with RalBP1 [6].
Interestingly, the EH domain of POB1 can bind Eps15, a
protein which lacks NPF motifs or other EH-binding
motifs (Figure 1). In particular, the POB1 binding-region
maps between amino acids 504–745 [14] and it contains
12 DPF (Aspartate-Proline-Phenylalanine) motifs. It has
been observed that the EH domain of Reps1, a protein
related but not identical to POB1, can bind to a peptide
containing a DPF motif [8]; furthermore, Cupers and col-
laborators reported the presence of tetramers of Eps15
and suggested that they might be stabilized by low-affinity
interactions between the N-terminal EH domains and the
DPF carboxy-terminal region [16].
The DPF region of Eps15 on the other hand, by binding to
the N-terminal "appendage" region of the AP-2 compo-
nent α-adaptin, is also involved in its recruitment to sites
of coated pit assembly [17,18].
In the present work, we have investigated the molecular
basis of the unconventional binding specificity of the
POB1 EH domain. By screening a multivalent nonapep-
tide phage display library, we have shown that this
domain can bind to both NPF- and DPF-containing pep-
tides. Moreover, we have mapped the region of Eps15
responsible for the interaction with the EH domain of
POB1 and compared it with the binding sites for the α-
adaptin subunit of the AP-2 complex. In addition, we sug-
gest that also the EH domain region of Eps15 associates
with the DPF region, albeit with lower affinity, thus sup-
porting its involvement in the stabilization of Eps15
tetramers.
Finally, based on the NMR structures of both EH domains,
we have hypothesized that lysine residues, distal to the
binding pocket, are potentially involved in the interaction
with Eps15. Altogether, these results show that the pep-
tide recognition specificity of the EH domain of POB1 dif-
fers from other EH domains since it interacts with both
NPF- and DPF-containing sequences; these unusual bind-
ing properties could be attributed to a different conforma-
tion of the binding pocket that allows to accommodate
negative charges.
Results
The EH domain from POB1 binds to NPF- and DPF-
containing peptides
To investigate the binding specificity of the POB1 EH
domain, we expressed it as a fusion to glutathione S-trans-
ferase (GST) and used it to screen a random nonapeptide
phage-display library as previously described [19,20]. 50
clones surviving three panning cycles were further tested
by phage ELISA. The 37 phages passing this second test
display one of 9 different peptides, 8 of which contain a
conventional EH binding motif (NPF: asparagine-proline-
phenylalanine) (Fig. 2). The remaining 4 phage clones
display the same peptide containing a DPF motif (DPF:
aspartate, proline, phenylalanine). The ELISA assay
shown in Figure 2 compares the differences in binding
affinities between all the selected peptides.
Thus, differently from EH domains whose recognition
specificities have been described so far, the POB1 EH
domain binds also to a peptide containing a DPF-motif.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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Furthermore, the selected peptide has a second negatively
charged residue at position +1 (aspartate), at variance
with the known sequence preferences of EH domains,
which dislike negatively charged residues at the positions
flanking the NPF tripeptide [7].
Finally, when all the selected NPF peptides are considered
together no strong preference can be identified in the
positions immediately preceding or following the NPF
motif, suggesting that the EH domain of POB1 is less
selective when compared to other EH domains described
in the literature. This is confirmed by ELISA experiments
carried out with purified peptides (not shown).
POB1 binds DPF motifs in Eps15
The results so far indicate that the POB1 EH domain can
bind DPF peptides displayed on filamentous phage and
suggest that this novel binding specificity could be
responsible for the recognition of the Eps15 C-terminal
domain. To map the Eps15 sequences responsible for
binding to POB1 we expressed as GST fusions progressive
COOH-terminal (10 amino acids) deletions of the region
spanning amino acids 623–743 of mouse Eps15 (Fig. 3A)
[18]. Agarose-immobilized GST-Eps15 fusion proteins
were tested in a pull-down assay carried out on
293Phoenix cells over-expressing full-length POB1 fused
to the Myc epitope. The results reported in Figure 3B indi-
Domain organization of human POB1 and human Eps15 proteins Figure 1
Domain organization of human POB1 and human Eps15 proteins. The domain structure of hPOB1 (Swiss Prot entry: 
Q8NFH8) and of hEps15 (Swiss Prot entry: P42567) and their binding partners are illustrated ([17, 26, 30-36]). Abbreviations: 
EH, Eps15 Homology; RalBP1-BD, RalA binding protein 1-binding protein; CC, Coiled-Coil region; UIM, Ubiquitin Interact-
ing Motif; Epsin, Eps-15 Interacting protein; Eps-15, Epidermal growth factor receptor pathwat substrate 15; Grb2, growth 
factor receptor-bound protein 2; PAG2, Paxillin-associated protein with ARFGAP activity 2; AP180, Clathrin coat assembly 
protein AP180; Hrb, HIV-1 Rev-binding protein.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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cate that the binding of the POB1 EH domain to the C-ter-
minal region of Eps15 is influenced in a complex manner
by the length of the region. Shortening of the 121 amino
acid DPF rich fragment initially results in negative modu-
lation of binding (see constructs D, F and G); further
shortening, however, restores efficient binding. A C-termi-
nal fragment (N in Fig 3A) is also capable of binding.
These results are compatible with the presence of at least
two different binding sites with fragment length affecting
conformation and, as a consequence, availability of DPF
motifs for EH binding.
In order to confirm the EH targets inferred by the pull
down experiment, we synthesized the full-length human
Eps15 protein as 15 amino acid long peptides, overlap-
ping by 12 amino acids, using the SPOT synthesis method
[21]. The membrane was incubated with the EH domain
of POB1 fused to GST and probed with an anti-GST anti-
body (Fig. 4). The results are partially in agreement with
the conclusions drawn from the pull-down experiments.
POB1_EH binds to DPF peptides in the regions 623–633
(a) and 647–674 (b); these findings are consistent with
the pull down results as the sequences (a) and (b) are also
present in the C and D constructs (see Fig. 3A). In addi-
tion, two more regions, both containing DPF peptides
and encompassing respectively amino acids 592–606 (c)
and 796–813 (d) also associate to POB1_EH domain.
However, both regions, which may contribute to stabilize
binding, are outside the fragments used in the pull-down
experiment. Finally, the spots encompassing the sequence
The EH domain of POB1 binds to both NPF and DPF-containing peptides Figure 2
The EH domain of POB1 binds to both NPF and DPF-containing peptides. Above: phage clones displaying different 
peptides were adsorbed to a plastic microtiter plate and incubated with the EH domain of POB1 fused to GST and GST alone 
as negative control. The bound domain was identified with an anti-GST antibody and a secondary antibody linked to alkaline 
phosphatase; wt is a phage not exposing any ectopic peptide. Below: sequences of the selected peptides are aligned with 
respect to the NPF and DPF motifs.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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of the N construct in the GST pull-down fail to associate
with the EH domain.
By combining the results from pull down and the PepSpot
experiments we conclude that many DPF peptides have
the potential of binding the EH domain of POB but most
of the Eps15 binding determinants are included in the
fragment encompassing amino acids 623–670 and con-
taining five DPF motifs. Furthermore, the two N-terminal
DPF peptides included in the region from D623 to D633 are
sufficient to promote binding to POB1_EH. Finally, the
results suggest that some of the determinants involved in
this interaction might promote a conformation necessary
for binding without being involved in the establishment
of contacts or, as an alternative, they could act as recogni-
tion sites for other binding partners which promote the
association.
Cupers and collaborators proposed that Eps15 forms a
head to head dimer and that two dimers further associate
head to tail to form a tetramer [16]. The tetrameric head
to tail structure suggests a possible interaction between
the EH domains at the N-terminus of Eps15 and the C-ter-
minal tail which contains 15 DPF repeats.
To test this hypothesis, we expressed as GST-fusions the
N-terminal region of mouse Eps15 and we compared it
with the EH domain of POB1 in a pull-down experiment:
The EH domain of POB1 binds to an 18 amino acids fragment comprising residues 623–640 and including three DPF Figure 3
The EH domain of POB1 binds to an 18 amino acids fragment comprising residues 623–640 and including 
three DPF. (A) Schematic representation of the C-terminal DPF-region of mouse Eps15, spanning amino acids 623–750 and 
comprising 10 DPF tripeptides. The recombinant proteins are progressive COOH-terminal deletions of 10 amino acids fused 
to the GST. The bars represent the protein fragments that are retained in the recombinant protein. The DPF motifs are indi-
cated by asterisks. (B) Lysates of Hek 293Phoenix expressing Myc-POB1 were incubated with GST or equal amounts of the 
recombinant proteins bound to glutathione-sepharose beads. Adsorbed proteins were identified with anti-Myc antibody. In the 
lower panel the GST fusions are visualized with Coomassie staining.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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POB1 associates with DPF-containing peptides in the C-terminus of Eps15 Figure 4
POB1 associates with DPF-containing peptides in the C-terminus of Eps15. (A) Full-length human Eps15 was synthe-
sized as 15 amino acid peptides, overlapping by 12 amino acids, on a cellulose membrane using the SPOT synthesis method 
[21]. The membrane was incubated with the EH domain of POB1 fused to the GST and probed with an anti-GST antibody. The 
groups of spots considered to be positives are indicated as a, b, c and d. Positives controls, binding to secondary antibodies, are 
indicated with rectangles. (B) Amino acid sequence of human Eps15. The N-terminal region comprising the three EH domains 
is underlined, sequences corresponding to the spots considered to be positives are outlined. Residues corresponding to the 
indicated regions are: a (aa 623–633), b (aa 647–674), c (aa 592–606) and d (aa 796–813).BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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50 µg of purified molecules bound to glutathione-sepha-
rose beads were incubated with 3 mg of cell extract from
Hek293. Bound proteins were resolved by SDS-PAGE and
analyzed by western-blotting using an anti-Eps15 anti-
body. The result shown in figure 5A confirms that both
the POB1_EH domain and the N-terminal region of
Eps15 associates to full length Eps15. A similar experi-
ment was carried out with the isolated GST-EH domains
(EH1, EH2, EH3) indicating that the association is medi-
ated by the N-terminal EH domain (EH1) of Eps15 (Fig.
5B).
In order to provide further evidence for the interaction of
Eps15 with the N-terminal EH domain, we performed a
pull-down assay using recombinant deletion constructs of
Eps15, spanning the DPF region. The GST fusions were
incubated with a Hek293 cell extract. Affinity purified
proteins were resolved by SDS-PAGE and analyzed by
western-blotting using an anti-Eps15 antibody to identify
endogenous Eps15. The result (Fig. 6) shows an associa-
tion that involves DPF triplets at the C-terminal end of
Eps15. Although these experiments don't definitively
prove a direct DPF/EH interaction in Eps15, as we cannot
exclude the involvement of accessory proteins, they con-
firm a plausible role of EH-DPF interaction in the stabili-
zation of Eps15 tetramers, as suggested by other authors
[16].
Lysine residues distal to the binding pocket are involved in 
POB1 EH/DPF interaction
NMR studies of the EH2 domain of Eps15, combined with
mutational analysis, have identified a patch of hydropho-
The amino-terminal EH domain of Eps15 associates with full length Eps15 Figure 5
The amino-terminal EH domain of Eps15 associates with full length Eps15. (A) The EH domain of POB1 and the N-
terminal region of Eps15 comprising three EH domains (EH1-EH2-EH3) were tested in a pull-down experiment from Hek293 
to evaluate the relative binding efficiency towards endogenous Eps15. (B) The isolated GST-EH domains (EH1, EH2, EH3) and 
the N-terminal region of Eps15 were tested in a similar experiment. The input lane corresponds to 0,1% of the lysate. Relative 
binding efficiencies represent the quantification of the Western blotting using the Image Quant Software. In the lower panel, 
the GST fusions are visualized by Coomassie staining.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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bic residues (Trp169, Val151, Leu155 and Leu165)
accommodating the proline in the NPF ligand (Fig. 7A).
Residues Gly148, Val162 and Gly166 delineate the edge
of the binding pocket where they may contribute to EH
recognition specificity. Finally, the side chains of Lys152
and Glu170 are positioned to form a sort of gate flanking
the binding groove [9]. It has been suggested that the elec-
trostatic repulsion from the negatively charged side chains
in the gate structure may prevent the interaction with a
peptide containing an aspartate in place of the asparagine
of the NPF motif.
The EH1 domain of Eps15 contains a similar hydrophobic
binding pocket as the EH2 domain [12] delimitated by
residues Ala40, Leu43, Ala53, Gly54 and Trp57, while
Lys44 and Asp58 form the gate of the pocket (Fig. 7B, left
panel).
The corresponding residues in the POB1 EH domain are
arranged differently [8,22], thus designing a groove with
different properties (Fig. 7C, left panel). Some residues
such as Phe310 and Ala306 (corresponding to Leu155
and Val151 in EH2_Eps15) are less exposed to the sol-
vent, moreover, the side chain of Lys307 (corresponding
to Lys152 in EH2_Eps15) points toward the pocket, par-
tially occluding it. Kim and co-workers determined the
solution structure of the EH domain of Reps1 and charac-
terized its binding to different peptides. Based on fast
exchange binding analysis, they observed that residues in
Reps1 corresponding to Trp324, Glu325 and Ser321 of
POB1 do not shift upon addition of a DPF-containing
peptide despite these residues showing the largest changes
on binding NPF. Furthermore, the addition of DPF pep-
tides affects resonances of residues that are distal to the
primary interaction site (Gln240). In POB1_EH the resi-
due corresponding to Gln240 (Gln289) is close to Ile347
and proximal to a positively charged surface patch formed
by Lys312 and Lys351 (Fig. 7C, right panel).
These observations could indicate that the topology of the
POB1_EH complex bound to a DPF-containing peptide
differs somewhat from the topology of a corresponding
complex hosting a NPF peptide. Starting from this
hypothesis, we investigated the contribution to Eps15
binding of the molecular surface of the POB1_EH domain
as defined by the side chains of residues Ile347 and
Phe344 and by the positive patch formed by Lys213 and
Lys351 in the interaction with Eps15. To this end, we
designed four POB1-EH mutant domains containing an
Ala side chain at position K312, K351, and F344 respec-
tively. A mutant in the conserved tryptophan (W324A)
was also added as a control since this residue was already
proven to be involved in NPF recognition. When tested in
a pull down assay, mutants K312A, K351A and the double
mutant K312A-K351A, similarly to W324A, have lost their
ability to bind Eps15 (Fig. 8). By contrast F344A still binds
Eps15. A similar result was also obtained when the
mutants were tested in an Epsin1 pull down, although
POB1_EH binds Epsin1 NPF motifs (data not shown).
Taken together these results suggest that the EH domain of
POB1 associates with peptides containing NPF and DPF
The DPF region of Eps15 binds to Eps15 in a pull-down experiment Figure 6
The DPF region of Eps15 binds to Eps15 in a pull-down experiment. 50 µg of the Eps15 recombinant proteins span-
ning amino acids 623–750 and comprising 10 DPF tripeptides, as described in Figure 3, were incubated with a cell extract from 
Hek293. Bound proteins were resolved by SDS-PAGE and analyzed by western-blotting using an anti-Eps15 antibody.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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motifs and that residues that are distal to the previously
defined binding pocket may be involved in this recogni-
tion.
Finally, the structural analysis (Fig. 7B, right panel) shows
that the EH1 domain of Eps15 contains a hydrophobic
crevice located in analogous position to the one analyzed
by point mutations in the POB1_EH domain. Leu77 and
Val80 constitutes the hydrophobic core of the pocket
Structural analysis of the NPF-binding pocket of Eps15 (EH2) and POB1 EH domain Figure 7
Structural analysis of the NPF-binding pocket of Eps15 (EH2) and POB1 EH domain. Molecular surface represen-
tations of the NPF-binding pocket of the Eps15 EH2, PDB code: 1EH2 (A), Eps15 EH1, PDB code: 1QJT (B) and POB1, PDB 
code: 1IQ3 (C) EH domains. Residues in the hydrophobic groove are coloured in red, residues which line the edge of the 
binding pocket are in green while the gate charged residues are in blue. (B) Left panel: representation of the classical binding 
pocket of Eps15 EH1 domain. Right panel: residues distant from the binding pocket, which have been discussed in the text, are 
mapped on the molecular surface of Eps15. Lys 21 indicates the position of the binding pocket. (C) Left panel: representation of 
the classical binding pocket of POB1 EH domain. Right panel: residues mutated in this study are mapped on the molecular sur-
face of POB1. Lys 307 indicates the position of the binding pocket. Lysine residues are coloured in blue, Phe344 and Ile347 in 
red and Gln289 in orange. Molecular surfaces were generated with PyMol.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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while Tyr19 and Tyr22 are partially solvent exposed and
form the edges Finally two positively charged residues,
Lys21 and Arg102, surround this groove while Arg78, con-
tiguous to Tyr19, locates the charged guanidinium group
toward the centre of the pocket extending the bottom sur-
face. Interestingly, Whitehead and collaborators [12]
assert that the mutation of the three tyrosine residues
Tyr19, Tyr22, and Tyr23 of mEH1 in Eps15 abolishes its
mono-ubiquitination upon stimulation of the cells with
EGF, indicating a clear functional role of this region in the
regulation of Eps15.
Even if not supported by a mutational analysis, these
observations permit to suggest that also for this EH
domain residues, distal to the primary interaction site,
could be responsible for the EH/DPF interaction and for
the "unconventional" recognition specificity.
Mutations in lysine residues distant from the binding pocket affect the interaction of POB1 with Eps15 Figure 8
Mutations in lysine residues distant from the binding pocket affect the interaction of POB1 with Eps15. Residues 
K312, W324, F344 and K351 in the POB1-EH domain were changed into Ala and the recombinant proteins were tested in an 
Eps15 pull-down assay from Hek293. Bound proteins were resolved by SDS-PAGE and analyzed by western-blotting using an 
anti-Eps15 antibody. In the lower panel, the GST fusions are visualized by Coomassie staining. Relative binding efficiencies rep-
resent the quantification of the Western blotting using the Image Quant Software.BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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Discussion
EH-domain-containing proteins and their interaction
partners form a network involved in endocytic transport
[23]. They play regulatory roles in endocytic membrane
transport events and in actin dynamics. POB1 has been
involved in cell migration and receptor endocytosis for its
binding the paxillin-associated protein PAG2 [15] and for
its interaction with RalBP1, a GTPase-activating proteins
(GAPs) for the GTP binding proteins Rac1, CDC42 and
Ral [5,6]. Moreover, POB1 was reported to bind directly
Epsin and Eps15 with its EH domain [14]. This, in turn,
can lead to actin assembly and to the formation of mem-
brane ruffles and actin-rich filopodia [24].
Several studies have pointed out that peptides containing
NPF (asparagine-proline-phenylalanine) motifs are con-
sistently found in EH-domain ligands [25]. Structural
analyses of the domain ligand complex have demon-
strated that the asparagine in the NPF motif is in close
contact with a highly conserved tryptophan residue in a
hydrophobic pocket in the EH domain surface [9,11].
Mutation of this conserved tryptophan residue dramati-
cally impairs binding. A recent report has implicated a
positively charged residue on the opposite side of the NPF
binding pocket of some EH domains in phosphatidyli-
nositols binding, thus adding a new function to EH
domains [26].
Although EH domains have never been proven to bind to
DPF target peptides, the observation that the association
between the EH domain of POB1 and Eps15 is mediated
by a C-terminal region containing several DPF[14] has
lead to the proposal that some EH may be able to bind
DPF. In addition it has been suggested that the association
between the EH domains of Eps15 and its own DPF rich
C-terminus may favour Eps15 multimerization [16].
In the present study we confirm that the POB1 EH domain
can bind specific DPF motifs in the C-terminal region of
Eps15. This interaction was firstly demonstrated by pan-
ning a phage displayed peptide library. With the SPOT
synthesis method we have been able to identify many DPF
peptides in the C-terminal region of Eps15 with the
potential of binding the EH domain of POB, most of them
included in the fragment encompassing amino acids 623–
670 and containing five DPF motifs. Clearly, a potentially
EH binding peptide identified in Eps15 with the SPOT
experiment could be buried inside the folded protein and
therefore it could be inaccessible to the interaction part-
ner. On the other hand, the previous findings are consist-
ent with the pull-down results as the same sequences also
associate to POB1_EH domain. Therefore, the overlap
between the results obtained by different approaches con-
firms that the POB1_EH domain can bind DPF peptides
and, more in general, point out the effectiveness of com-
bining the classical pull-down method with the SPOT
technology to study protein interactions.
Furthermore, we suggest that a similar association
between the first EH domain of Eps15 and its C-terminus
could participate in the stabilization of Eps15 tetramers.
The DPF region of Eps15 is also the binding site for the
AP-2 complex, the adaptor which connects the clathrin
lattice to the plasma membrane and interacts with tyro-
sine-based signals of several integral membrane proteins
[27]. The binding site of AP-2 spans amino acids 668–744
in mouse Eps15, which corresponds to residues 667–739
of the human Eps15 [17]. The EH domain of POB1 binds
Eps15 in the region encompassing amino acids 623–670.
Thus the POB1 and AP2 binding sites on Eps15 are close
but distinct; moreover, neither of these sites coincide with
the Crk binding site (residues 768–778 in hEps15) [28],
suggesting that the binding of these proteins to Eps15 may
not be mutually exclusive. On the other hand the EH of
POB1 and the first EH domain of Eps15 both bind to the
C-terminal DPF region and compete for the same ligand.
It is tempting to speculate that the multimerization of
Eps15, stabilized by the interaction between the N-termi-
nal EH and the C-terminal DPF region, may modulate the
interaction between POB1 and Eps15.
Structural and mutational analysis of several EH domains
clearly demonstrate that the conserved tryptophan at the
base of the NPF binding pocket is essential for domain
functionality, while residues flanking the binding groove
can influence specificity. For example, the EH3 domain of
Eps15 binds to a peptide mimicking the FW-internaliza-
tion motif of MPR; moreover, NMR and mutational anal-
ysis unequivocally shows that FW and NPF peptides bind
in the same pocket and involve the same residues [10].
Nonetheless, while mutation of residues in the binding
site such as Phe252 and Arg249 substantially affect EH3
ligand binding, the corresponding mutants in the residues
Leu155 and Lys152 in EH2 do not affect binding [10].
The mutational analysis reported in our manuscript con-
firms that the conserved tryptophan in the binding pocket
of POB1_EH domain is essential for peptide recognition,
since the mutation W324A affects the interaction with
both NPF- and DPF peptides. In addition we provide evi-
dence that the lysine residues K312 and K351, which are
distal to the binding pocket, are involved in this recogni-
tion. On the contrary, mutating Phe344 to Ala doesn't
affect binding.
Conclusion
In the present study we have shown that the EH domains
of POB1 binds the c-terminus of Eps15 thanks to its affin-
ity for DPF containing peptides. In addition we have iden-BMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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tified a cluster of solvent exposed Lys residues, which are
only found in the EH domain of POB1, and influence
binding to both NPF and DPF motifs. None of the
mutants that we have characterized so far show a preferen-
tial binding for either NPF or DPF motifs suggesting that
the two motifs have a similar binding mode and that both
NPF and DPF binding require the hydrophobic pocket
characterized in structural studies and the positively
charged surface patch characterized in this study. The
involvement of the positive patch, either by direct DPF
binding or indirectly by modification of the tryptophan
binding pocket, cannot be reconciled with the informa-
tion provided by the structure of the peptide EH com-
plexes described so far and the rationalization of these
findings must await the characterization of structures of
the DPF ligands described in this study and the POB1 EH
domain.
Methods
Plasmid vectors and cDNA constructs
The plasmid vectors encoding mouse GST-Eps15 C-termi-
nal constructs were a generous gift from G. Iannolo [18].
The fragments cloned in pGEX expression vector corre-
sponds to the following residues: (A) 623–640, (B) 623–
650, (C) 623–660, (D) 623–670, (E) 623–680, (F) 623–
690, (G) 623–700, (H) 623–710, (I) 623–720, (L) 623–
730, (M) 623–743, (N) 670–743. Cloning of human N-
terminal region (EH1-EH2-EH3) has been described pre-
viously [7]. The vector encoding human POB1 (Swiss-prot
accession number: Q8NFH8) was obtained by PCR
amplification of the full-length sequence from a human
brain cDNA library; after digestion with BamHI and NotI
restriction enzymes the fragment was cloned in pcDNA
3.1 vector containing the Myc epitope tag. The GST fusion
protein containing the EH domain of POB1 was obtained
by PCR amplification of the region corresponding to resi-
dues 266–365, the fragment was digested with BamHI
and EcoRI restriction enzymes and cloned in pGEX-2TK.
Site-specific mutagenesis
The following primers were used to insert the mutations
in the EH domain of POB1. CCAAGAACTTCTTCACCG-
CATCAAAGCTTTCCATTCC for the mutation K312A,
AGAACTCTCCTATATAGCGGAGCTTAGTGATGCTG for
the mutation W324A, TGAGTTCTGTGCTGCGGCT-
CATCTCATTGTGGCTC for the mutation F344A, CAAT-
GGGTAGCCGTTCGCCCGAGCCACAATGA for the
mutation K351A. Mutations were inserted using the Strat-
agene's QuikChange Mutagenesis Kit.
Antibodies
The following primary antibodies were used in the exper-
iments: rabbit anti-Eps15 (Santa Cruz), goat anti-GST
(Amersham Bioscience, Inc.), rabbit anti-Myc (Invitro-
gen) and rabbit anti-Epsin1 (a gift from G. Cestra). Sec-
ondary antibodies used in this work were secondary anti-
goat monoclonal alkaline phosphatase-conjugated anti-
body (Sigma), anti-goat IgG peroxidase conjugated
(SIGMA), anti-rabbit peroxidase-conjugated IgG and anti-
mouse peroxidase-conjugated IgG (Jackson ImmunoRe-
search).
Affinity selection
Library construction and panning were performed as
described [19,29]. Briefly, 2–20 µg of GST fusion protein
bound to glutathione-Sepharose 4B gel (Amersham Phar-
macia Biotech) were incubated with 1010 infectious parti-
cles from a nonapeptide library. After washing 10times
with PBS, 0.5% Tween 20, the bound phages were eluted
with 100mM glycine HCl, pH 2.2. After three selection
cycles, the binding of isolated clones was confirmed by
ELISA.
Bacteriophage ELISA
Microtiter wells were coated with 109 particles and incu-
bated with 0.2 µg of GST fusion protein. The wells were
then washed 10times with PBS, 0.1Tween 20, and bound
protein was detected with anti-GST goat primary antibody
(Amersham Pharmacia Biotech) and a secondary anti-
goat monoclonal alkaline phosphatase-conjugated anti-
body (Sigma). Clones with binding activity were selected
for further analysis. The sequence of the peptides dis-
played by positive clones were determined by automatic
(ABI PRISM 310Perkin-Elmer) sequencing of phage sin-
gle-stranded DNA using universal M13-40 primer. For the
ELISA with synthetic peptides, biotinylated peptides were
bound to microtiter wells coated with 1 µg of streptavidin.
Each well was incubated with 0,25 µg of GST-EH domain
hybrid protein and the bound domain revealed with an
anti GST antibody.
Cell culture and transfection
293 cells were grown at 37°C in a 5% CO2 incubator, in
DMEM (Gibco/Invitrogen) supplemented with 10% fetal
bovine serum (FBS) (SIGMA-Aldrich) and penicillin and
streptomycin (Gibco/Invitrogen). Cells were transiently
transfected with Lipofectamine 2000 reagent (Invitrogen)
according to manufacture's instructions; alternatively,
cells were transiently transfected with the calcium-phos-
phate method.
Transient transfection with calcium-phosphate method
One day prior to transfection, 293 cells were plated on 10
cm dish to achieve 60–70% of confluence at the time of
the transfection. Briefly, 10 µg of each DNA were diluted
in ddH2O with 61 µl of 2 M CaCl2 to a final volume of 500
µl into a 2 ml tube. Drops of this DNA and CaCl2 mixture
were added into a 15 ml tube containing 500 µl of HBS 2x,
pH 7,05 (50 mM Hepes, 10 mM KCl, 12 mM dextrose,
280 mM NaCl, 1,5 mM Na2HPO4) while blowing bubblesBMC Biochemistry 2007, 8:29 http://www.biomedcentral.com/1471-2091/8/29
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into the tube with a 2 ml pipet. The mixture was main-
tained at room temperature for 20 minutes, then the
DNA-CaPO4 co-precipitated drops were added to the sur-
face of the media containing the cells and the plate was
gently swirled to mix. After 8–16 hours the CaPO4 con-
taining medium was removed and replaced with normal
medium. Transient assays for gene expression in trans-
fected cells were performed 24–72 hours post transfec-
tion.
GST-fusion proteins purification
All constructs were transformed into E.coli  BL21(DE3)
strain. Cultures were grown overnight in LB medium sup-
plemented with ampicillin and used to inoculate fresh
medium (v/v 1:100). The culture were subsequently
grown to OD600 = 0,6 and induced for 4 hours at 30°C
with 0,5 mM IPTG. Cells were collected by centrifugation
and resuspended in 1/50 of the original volume with STE
buffer (10 mM Tris-HCl pH 8, 100 mM NaCl, 1 mM
EDTA, Triton 1%) supplemented with protease inhibitor
cocktail (SIGMA-Aldrich). For the purification of wild-
type and mutated EH domains, cells were resuspended in
EH buffer (Tris pH 7,5 50 mM, NaCl 100 mM, CaCl2 5
mM, DTT 2 mM, PMSF 1 mM, Triton 1%, Leupeptin 5 µg/
ml, Aprotinin 5 µg/ml). Cells were disrupted by sonica-
tion and the lysates were clarified by centrifugation. To
purify GST-fusion proteins from the extract, the lysates
were incubated with glutathione-Sepharose 4B beads
(Amersham Bioscience Inc.) for 1 hour at 4°C, then
washed 5 times with ice-cold PBS. Were necessary, pro-
teins were eluted from the beads by incubating them with
15 mM glutathione and eluted proteins were subjected to
dialysis in cold PBS.
Pull-down
GST-fusion proteins and GST alone were expressed in bac-
teria, adsorbed to glutathione-Sepharose beads (Amer-
sham Bioscience, Inc.) and incubated for 2 hours at 4°C
with 1 mg of 293 cellular extract in EH buffer. Beads were
then washed 3 times with the lysis buffer and bound pro-
teins were electrophoresed on a 10% polyacrylamide gel,
transferred onto nitrocellulose membrane and probed
with specific antibodies. Detection was performed with
the enhanced chemoluminescence Supersignal West Pico
Stable Peroxidase Solution (Pierce).
Peptide array synthesis
The peptide arrays (15 amino acid long) were synthesized
on cellulose-(3-amino-2-hydroxy-propyl)-ether (CAPE)
membranes, because of a better signal-to-noise ratio in
the incubation experiments.
Preparation of CAPE membranes: a 18 × 28 cm Whatman
50 paper (Whatman, Maidstone, United Kingdom) was
immersed in a stainless steel dish containing a solution of
400 mg of p-toluenesulfonic acid in methanol (50 ml)
and shaken for 3 min. The membrane was removed from
the tray and air-dried. Meanwhile a solution of 7.8 g of N-
(2,3- epoxypropyl)-phathalimid in dioxane (60 ml) was
heated to 80°C in a covered stainless steel dish placed on
a shaking platform. Then, a solution of 400 mg of p-tolue-
nesulfonic acid in 5 ml of dioxane was added. The mem-
brane was placed in this solution and shaken at 80°C for
3–5 hours. Afterwards, the membrane was washed three
times with 50 ml of dioxane and with ethanol (twice, 50
ml each) and subsequently incubated with a 10% (v/v)
solution (50 ml) of hydrazine hydrate (80%) in ethanol
for approximately 6 hours. Finally, the membrane was
washed twice with ethanol, three times with dimethyl-
acetamide, and once again with ethanol (twice, 50 ml
each), and dried. The peptide loading of this type of
amino-functionalized cellulose membrane is about 120–
200 nmol/cm2.
Peptides were synthesized according to standard SPOT
synthesis protocols (Frank 1992) using an automatic spot
synthesizer (Abimed, Langenfeld, Germany) as described
in detail (Kramer and Schneider-Mergener 1998).
Incubation with the domain was performed with 10 µg/
ml of the GST-fused domain in blocking buffer overnight
at 4°C. After washing three times for 10 min with TBS, the
anti-GST monoclonal antibody (G1160; Sigma) was
added at a concentration of 1 µg/ml in blocking buffer for
2 hours at room temperature. After three washings with
TBS (10 minutes each) a POD-labeled anti-mouse mAb (1
µg/ml in blocking buffer) was added and incubated for
1.5 hours at room temperature, followed by washing three
times with TBS.
Quantization of peptide-bound domain was carried out
using a chemoluminescence substrate and the Lumi-
ImagerTM instrument (Roche Diagnostics, Basel, Switzer-
land). Signal intensities were measured in BLUs (Boher-
inger Light Units).
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